HitGen Inc
SSE:688222

Watchlist Manager
HitGen Inc Logo
HitGen Inc
SSE:688222
Watchlist
Price: 29.07 CNY -1.29% Market Closed
Market Cap: ¥11.6B

Net Margin

15.4%
Current
Improving
by 3.8%
vs 3-y average of 11.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
15.4%
=
Net Income
¥65.7m
/
Revenue
¥426.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
15.4%
=
Net Income
¥65.7m
/
Revenue
¥426.3m

Peer Comparison

Country Company Market Cap Net
Margin
CN
HitGen Inc
SSE:688222
11.7B CNY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
193.8B USD
Loading...
US
Danaher Corp
NYSE:DHR
148.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
136.7T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
36B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
284.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
35.2B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.1B USD
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
27.9B USD
Loading...
CN
WuXi Biologics (Cayman) Inc
HKEX:2269
168B HKD
Loading...

Market Distribution

Higher than 82% of companies in China
Percentile
82nd
Based on 8 721 companies
82nd percentile
15.4%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

HitGen Inc
Glance View

HitGen, Inc. engages in the provision deoxyribonucleic acid encoded compound library (DEL) for research and development of seed and lead compounds. The company is headquartered in Chengdu, Sichuan and currently employs 508 full-time employees. The company went IPO on 2020-04-16. The firm focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The firm mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The firm conducts its businesses within the domestic market and to overseas markets.

HitGen Inc Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
15.4%
=
Net Income
¥65.7m
/
Revenue
¥426.3m
What is HitGen Inc's current Net Margin?

The current Net Margin for HitGen Inc is 15.4%, which is above its 3-year median of 11.6%.

How has Net Margin changed over time?

Over the last 3 years, HitGen Inc’s Net Margin has decreased from 16.1% to 15.4%. During this period, it reached a low of 7% on Mar 31, 2023 and a high of 16.1% on Mar 3, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett